Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=24437490
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\24437490
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Endocrinology
2014 ; 155
(4
): 1207-21
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Metformin inhibits androgen-induced IGF-IR up-regulation in prostate cancer cells
by disrupting membrane-initiated androgen signaling
#MMPMID24437490
Malaguarnera R
; Sacco A
; Morcavallo A
; Squatrito S
; Migliaccio A
; Morrione A
; Maggiolini M
; Belfiore A
Endocrinology
2014[Apr]; 155
(4
): 1207-21
PMID24437490
show ga
We have previously demonstrated that, in prostate cancer cells, androgens
up-regulate IGF-I receptor (IGF-IR) by inducing cAMP-response element-binding
protein (CREB) activation and CREB-dependent IGF-IR gene transcription through
androgen receptor (AR)-dependent membrane-initiated effects. This IGF-IR
up-regulation is not blocked by classical antiandrogens and sensitizes cells to
IGF-I-induced biological effects. Metformin exerts complex antitumoral functions
in various models and may inhibit CREB activation in hepatocytes. We, therefore,
evaluated whether metformin may affect androgen-dependent IGF-IR up-regulation.
In the AR(+) LNCaP prostate cancer cells, we found that metformin inhibits
androgen-induced CRE activity and IGF-IR gene transcription. CRE activity
requires the formation of a CREB-CREB binding protein-CREB regulated
transcription coactivator 2 (CRTC2) complex, which follows Ser133-CREB
phosphorylation. Metformin inhibited Ser133-CREB phosphorylation and induced
nuclear exclusion of CREB cofactor CRTC2, thus dissociating the CREB-CREB binding
protein-CRTC2 complex and blocking its transcriptional activity. Similarly to
metformin action, CRTC2 silencing inhibited IGF-IR promoter activity. Moreover,
metformin blocked membrane-initiated signals of AR to the mammalian target of
rapamycin/p70S6Kinase pathway by inhibiting AR phosphorylation and its
association with c-Src. AMPK signals were also involved to some extent. By
inhibiting androgen-dependent IGF-IR up-regulation, metformin reduced
IGF-I-mediated proliferation of LNCaP cells. These results indicate that, in
prostate cancer cells, metformin inhibits IGF-I-mediated biological effects by
disrupting membrane-initiated AR action responsible for IGF-IR up-regulation and
suggest that metformin could represent a useful adjunct to the classical
antiandrogen therapy.